Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (51-60 of 400) with videos related to

Pageof 40
Sort By:
Psychopharmacology Bulletin|January 1, 1988
Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic functionV Haroutunian, P Knott, K L Davis
Biological Psychiatry|January 15, 1988
Pisa syndrome in Alzheimer's diseaseM Davidson, P Powchik, K L Davis
Harefuah|December 15, 1987
[Cholinergic agents in the treatment of Alzheimer's disease]Z Zemishlany, M Davidson, K L Davis
Psychopharmacology|January 1, 1985
Cholinergic modulation of memory in ratsV Haroutunian, E Barnes, K L Davis
Schizophrenia Bulletin|January 1, 1992
Homovanillic acid measurement in clinical research: a review of methodologyF Amin, M Davidson, K L Davis
Life Sciences|September 9, 1985
Pharmacological alleviation of cholinergic lesion induced memory deficits in ratsV Haroutunian, P Kanof, K L Davis
The Journal of Biological Chemistry|October 25, 1996
Protein kinase C-epsilon is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. Evidence for discrete signals for growth and differentiationY Li, K L Davis, A J Sytkowski
Biological Psychiatry|January 23, 1999
Pharmacologic strategies for augmenting cognitive performance in schizophreniaJ I Friedman, H Temporini, K L Davis
European Journal of Biochemistry|December 1, 1993
Alanine scanning mutagenesis of human erythropoietin identifies four amino acids which are critical for biological activityJ Grodberg, K L Davis, A J Sykowski
Psychopharmacology|January 31, 1978
Cholinergic inhibition of methylphenidate-induced stereotypy: oxotremorineK L Davis, L E Hollister, J Tepper
Pageof 40

Showing results (51-60 of 400) with videos related to

Sort By:
Pageof 40
Psychopharmacology Bulletin|January 1, 1988
Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic functionV Haroutunian, P Knott, K L Davis
Biological Psychiatry|January 15, 1988
Pisa syndrome in Alzheimer's diseaseM Davidson, P Powchik, K L Davis
Harefuah|December 15, 1987
[Cholinergic agents in the treatment of Alzheimer's disease]Z Zemishlany, M Davidson, K L Davis
Psychopharmacology|January 1, 1985
Cholinergic modulation of memory in ratsV Haroutunian, E Barnes, K L Davis
Schizophrenia Bulletin|January 1, 1992
Homovanillic acid measurement in clinical research: a review of methodologyF Amin, M Davidson, K L Davis
Life Sciences|September 9, 1985
Pharmacological alleviation of cholinergic lesion induced memory deficits in ratsV Haroutunian, P Kanof, K L Davis
The Journal of Biological Chemistry|October 25, 1996
Protein kinase C-epsilon is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. Evidence for discrete signals for growth and differentiationY Li, K L Davis, A J Sytkowski
Biological Psychiatry|January 23, 1999
Pharmacologic strategies for augmenting cognitive performance in schizophreniaJ I Friedman, H Temporini, K L Davis
European Journal of Biochemistry|December 1, 1993
Alanine scanning mutagenesis of human erythropoietin identifies four amino acids which are critical for biological activityJ Grodberg, K L Davis, A J Sykowski
Psychopharmacology|January 31, 1978
Cholinergic inhibition of methylphenidate-induced stereotypy: oxotremorineK L Davis, L E Hollister, J Tepper
Pageof 40